These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35771275)

  • 1. Two plus One: Combination Therapy Tri-systems Involving Two Membrane-Disrupting Antimicrobial Macromolecules and Antibiotics.
    Shao Z; Wulandari E; Lin RCY; Xu J; Liang K; Wong EHH
    ACS Infect Dis; 2022 Aug; 8(8):1480-1490. PubMed ID: 35771275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy between Synthetic Antimicrobial Polymer and Antibiotics: A Promising Platform To Combat Multidrug-Resistant Bacteria.
    Namivandi-Zangeneh R; Sadrearhami Z; Dutta D; Willcox M; Wong EHH; Boyer C
    ACS Infect Dis; 2019 Aug; 5(8):1357-1365. PubMed ID: 30939869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro assessment of the antibacterial effects of the combinations of fosfomycin, colistin, trimethoprim and nitrofurantoin against multi-drug-resistant Escherichia coli.
    Mohamed Abu El-Wafa W; Abouwarda AM
    Lett Appl Microbiol; 2022 Mar; 74(3):334-343. PubMed ID: 34839528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia.
    Betts JW; Phee LM; Woodford N; Wareham DW
    Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1565-72. PubMed ID: 24781003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-Vitro Evaluation of Different Antimicrobial Combinations with and without Colistin Against Carbapenem-Resistant
    Oliva A; Garzoli S; De Angelis M; Marzuillo C; Vullo V; Mastroianni CM; Ragno R
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30832412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa.
    Akbari R; Hakemi-Vala M; Pashaie F; Bevalian P; Hashemi A; Pooshang Bagheri K
    Microb Drug Resist; 2019 Mar; 25(2):193-202. PubMed ID: 30281385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Synergistic Effect of Mud Crab Antimicrobial Peptides Sphistin and Sph
    Liu J; Chen F; Wang X; Peng H; Zhang H; Wang KJ
    Front Cell Infect Microbiol; 2020; 10():572849. PubMed ID: 33194811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
    Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
    Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repositioning rafoxanide to treat Gram-negative bacilli infections.
    Miró-Canturri A; Ayerbe-Algaba R; Villodres ÁR; Pachón J; Smani Y
    J Antimicrob Chemother; 2020 Jul; 75(7):1895-1905. PubMed ID: 32240294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli.
    Wang Y; Li H; Xie X; Wu X; Li X; Zhao Z; Luo S; Wan Z; Liu J; Fu L; Li X
    J Glob Antimicrob Resist; 2020 Mar; 20():351-359. PubMed ID: 31557565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates.
    Jahangiri A; Neshani A; Mirhosseini SA; Ghazvini K; Zare H; Sedighian H
    Microb Pathog; 2021 Jan; 150():104700. PubMed ID: 33346078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New therapy from old drugs: synergistic bactericidal activity of sulfadiazine with colistin against colistin-resistant bacteria, including plasmid-mediated colistin-resistant mcr-1 isolates.
    Okdah L; Le Page S; Olaitan AO; Dubourg G; Hadjadj L; Rolain JM
    Int J Antimicrob Agents; 2018 May; 51(5):775-783. PubMed ID: 29421171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria
    Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T
    Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bithionol Restores Sensitivity of Multidrug-Resistant Gram-Negative Bacteria to Colistin with Antimicrobial and Anti-biofilm Effects.
    Guo W; Liu Y; Yao Z; Zhou H; Wang X; Huang Z; Zhang X; Wu Q; Zhou T
    ACS Infect Dis; 2023 Aug; 9(8):1634-1646. PubMed ID: 37458689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro synergy of colistin combinations against extensively drug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase.
    Wei W; Yang H; Liu Y; Ye Y; Li J
    J Chemother; 2016 Jun; 28(3):159-63. PubMed ID: 25978105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic activities of ceftazidime-avibactam in combination with different antibiotics against colistin-nonsusceptible clinical strains of
    Mataraci Kara E; Yilmaz M; İstanbullu Tosun A; Özbek Çelik B
    Infect Dis (Lond); 2020 Sep; 52(9):616-624. PubMed ID: 32427010
    [No Abstract]   [Full Text] [Related]  

  • 18. Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections.
    Phee LM; Betts JW; Bharathan B; Wareham DW
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4544-50. PubMed ID: 25987639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Synergistic Effects of Antimicrobial Combinations on Extensively Drug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Isolates.
    Lee H; Roh KH; Hong SG; Shin HB; Jeong SH; Song W; Uh Y; Yong D; Lee K
    Ann Lab Med; 2016 Mar; 36(2):138-44. PubMed ID: 26709261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing Azithromycin and Rifampicin Against Gram-Negative Pathogens by Combination With Peptidomimetics.
    Baker KR; Jana B; Hansen AM; Nielsen HM; Franzyk H; Guardabassi L
    Front Cell Infect Microbiol; 2019; 9():236. PubMed ID: 31334131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.